DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
| Revenue (TTM) | $13.64B |
| Gross Profit (TTM) | $4.40B |
| EBITDA | $2.75B |
| Operating Margin | 15.20% |
| Return on Equity | 64.80% |
| Return on Assets | 7.32% |
| Revenue/Share (TTM) | $183.80 |
| Book Value | $-9.50 |
| Price-to-Book | 21.63 |
| Price-to-Sales (TTM) | 0.72 |
| EV/Revenue | 1.618 |
| EV/EBITDA | 8.35 |
| Quarterly Earnings Growth (YoY) | 6.50% |
| Quarterly Revenue Growth (YoY) | 9.90% |
| Shares Outstanding | $65.94M |
| Float | $34.82M |
| % Insiders | 51.20% |
| % Institutions | 53.27% |
Volatility is currently contracting